PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Strathcona Resources Ltd (SCR.TO)
38.000.60 (1.60%)
37.15 - 38.24
22.75 - 39.30
1.11M / 91.9K (Avg.)
12.71 | 2.99
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.35%
Negative revenue growth while Technology median is 0.43%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-47.66%
Negative gross profit growth while Technology median is 1.87%. Seth Klarman would suspect poor product pricing or inefficient production.
-52.52%
Negative EBIT growth while Technology median is 4.80%. Seth Klarman would check if external or internal factors caused the decline.
-52.52%
Negative operating income growth while Technology median is 5.76%. Seth Klarman would check if structural or cyclical issues are at play.
-50.65%
Negative net income growth while Technology median is 4.39%. Seth Klarman would investigate factors dragging net income down.
-50.93%
Negative EPS growth while Technology median is 4.44%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-50.93%
Negative diluted EPS growth while Technology median is 4.99%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.12%
Share growth above Technology median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.09%
Diluted share change of 0.09% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
83683.39%
Dividend growth of 83683.39% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
-47.49%
Negative OCF growth while Technology median is 2.08%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
18.67%
FCF growth exceeding 1.5x Technology median of 3.19%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
5138.80%
10Y revenue/share CAGR exceeding 1.5x Technology median of 24.04%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
2312.54%
5Y revenue/share growth exceeding 1.5x Technology median of 16.22%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
8721.44%
3Y revenue/share growth exceeding 1.5x Technology median of 15.62%. Joel Greenblatt might see a short-term competitive advantage at play.
1495.00%
OCF/share CAGR of 1495.00% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
7912.94%
OCF/share CAGR of 7912.94% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
2916.11%
3Y OCF/share growth of 2916.11% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
413.51%
Net income/share CAGR exceeding 1.5x Technology median of 7.41% over a decade. Joel Greenblatt might see a standout compounder of earnings.
2754.76%
5Y net income/share CAGR > 1.5x Technology median of 7.10%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
369.01%
3Y net income/share CAGR > 1.5x Technology median of 3.17%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
1427.74%
Equity/share CAGR exceeding 1.5x Technology median of 7.34% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
5249.98%
5Y equity/share CAGR > 1.5x Technology median of 9.63%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
7987.16%
3Y equity/share CAGR > 1.5x Technology median of 10.44%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.39%
AR shrinking while Technology median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
2.16%
Asset growth exceeding 1.5x Technology median of 0.07%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
1.05%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
18.70%
Slightly rising debt while Technology median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
No Data
No Data available this quarter, please select a different quarter.
-0.46%
SG&A decline while Technology grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.